GCTK
Glucotrack, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · IL
$0.45
+2.27%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 4
Key dataNov 4, 2026
Open$0.44
From 52W high−99.56%
Volume2793.00
Market cap$532853.10
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$0.44
From 52W high
−99.56%
Volume
2793.00
Market cap
$532853.10
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.0x
P/E (TTM)
—
RSI (14)
31.4
MomentumView details →
1D Return
+2.27%
YTD Return
−99.22%
SummaryUpdated Jun 1, 2026
GlucoTrack, Inc. (NASDAQ:GCTK) is an Israeli medical device company founded in 2001 and headquartered in Or Yehuda, Israel. Originally established as Integrity Applications, Inc., the company rebranded to GlucoTrack in November 2021 to better reflect its focus on glucose monitoring technology. The company went public in April 2013 and specializes in developing non-invasive glucose monitoring devices for people with diabetes and pre-diabetes. Despite over two decades of development, GlucoTrack has yet to generate commercial revenue and remains in the research and development phase of bringing its flagship product to market.
Similar companies
Latest newsMore news →
NASDAQ, INC. notified Glucotrack, Inc. on October 28, 2026, that it was not in compliance with NASDAQ, INC. Listing Rule 5550(a)(2) because of a price deficiency and set a compliance deadline of November 9, 2026.6d agoGlucotrack, Inc. amended its September Notes to remove downward Floor Price adjustment provisions, make the Floor Price an absolute floor, and require any True-Up Amount to be paid only in cash.37d agoGlucotrack, Inc. announced the pricing of a $3 million public offering.41d ago